IGF1 and cancer: In addition to the insulin/IGF axis, increasing attention has focused on adipose tissue (AT) dysfunction characterized by a pro-inflammatory state, which can contribute not only to the pathogenesis of insulin resistance [21] but also to the development and promotion of cancer.